The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-(trifluoromethoxy)benzenesulfonamide
ID: ALA4741544
PubChem CID: 156635006
Max Phase: Preclinical
Molecular Formula: C14H10F6N2O3S
Molecular Weight: 400.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1C(F)(F)F
Standard InChI: InChI=1S/C14H10F6N2O3S/c15-13(16,17)11-7-8(1-6-12(11)21)22-26(23,24)10-4-2-9(3-5-10)25-14(18,19)20/h1-7,22H,21H2
Standard InChI Key: OVSKTYBCPRYLSH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
25.9231 -4.6514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5187 -3.9456 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.1097 -4.6488 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9370 -3.9456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9359 -4.7651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6439 -5.1741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3536 -4.7647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3507 -3.9420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6421 -3.5367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2292 -3.5372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8138 -3.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8172 -2.7197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1102 -2.3114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4017 -2.7202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4045 -3.5416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1120 -3.9463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0619 -5.1721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6437 -5.9913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9359 -6.3997 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.3513 -6.4001 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.6359 -6.8058 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.6933 -2.3127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9862 -2.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2779 -2.3149 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.9875 -3.5396 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.2759 -3.1243 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
23 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.30 | Molecular Weight (Monoisotopic): 400.0316 | AlogP: 3.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.41 | CX Basic pKa: 2.30 | CX LogP: 3.94 | CX LogD: 3.91 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.60 | Np Likeness Score: -1.52 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |